(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 166.59% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Dbv Technologies Sa's revenue in 2024 is $15,728,000.On average, 1 Wall Street analysts forecast DBVT's revenue for 2024 to be $1,333,651,379, with the lowest DBVT revenue forecast at $1,333,651,379, and the highest DBVT revenue forecast at $1,333,651,379. On average, 1 Wall Street analysts forecast DBVT's revenue for 2025 to be $10,789,750,745, with the lowest DBVT revenue forecast at $10,789,750,745, and the highest DBVT revenue forecast at $10,789,750,745.
In 2026, DBVT is forecast to generate $30,434,830,930 in revenue, with the lowest revenue forecast at $30,434,830,930 and the highest revenue forecast at $30,434,830,930.